IMedis vs Nucleai
IMedis vs Nucleai, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: IMedis is on 42/100 and Nucleai on 63/100.
Where each one leads
IMedis
- headcount growth: -3.5% against -7.0%
Nucleai
- our overall score: 63/100 against 42/100
- agent readiness: 42/100 against 22/100
- domain rating: 29/100 against 4/100
- headcount: 66 against 6
- funding raised: $58.5M against $1.3M
- LinkedIn following: 18,902 against 806
At a glance
| Measure | IMedis | Nucleai |
|---|---|---|
| What it is | AI-driven quality management system for radiology departments, reducing risk and improving financial efficacy. | AI-powered spatial biology platform for precision medicine and drug development. |
| Category | Healthcare, Diagnostics, Quality Assurance, HealthTech | Healthcare, Oncology, Pharmaceutical, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 2018 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | IMedis | Nucleai |
|---|---|---|
| Employees | 6 | 66 |
| Headcount growthLast 12 months | -3.5% | -7.0% |
| Total funding | $1.3M | $58.5M |
| Latest round | Not published | Series B |
| LinkedIn followers | 806 | 18,902 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | IMedis | Nucleai |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 63/100 |
| Traction | 39/100 | 57/100 |
| Team | 30/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 33/100 | 31/100 |
| Quality | 48/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 4/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | IMedis | Nucleai |
|---|---|---|
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Tag Manager, Linkedin Insight, Facebook Pixel |
| Support stack | Not detected | HubSpot |
IMedis vs Nucleai: common questions
Which is better, IMedis or Nucleai?
On our 0-100 score Nucleai rates higher (63/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do IMedis and Nucleai compare on the numbers?
IMedis leads on headcount growth (-3.5% against -7.0%). Nucleai leads on our overall score (63/100 against 42/100), agent readiness (42/100 against 22/100), domain rating (29/100 against 4/100), headcount (66 against 6), funding raised ($58.5M against $1.3M), LinkedIn following (18,902 against 806).
Read the full IMedis review and pricing or the Nucleai review and pricing. You can also browse other IMedis alternatives we track.